1 in 5 Veterans of the Iraq & Afghanistan wars have been diagnosed with PTSD. There are 1.7 Million Traumatic Brain Injuries in the United States every year. Brainsway, a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience today announced the launch of a new research collaboration with the Stanford University School of Medicine to identify potential biomarkers in patients suffering from Post Traumatic Stress Disorder (PTSD). June 27th is PTSD Awareness Day The goal of PTSD Awareness Day is to spread awareness about PTSD symptoms and effects, as well as advance the discussion about diagnosis, treatment, and care for those suffering from the effects of trauma.RECENT NEWS
GET UPDATES
Advancing Brain Health
We are dedicated to fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma to the brain.
PTSD
8% of people have PTSD at some point during their lives.TBI
5.3 Million suffer from TBI-induced disabilities.We Need Precision Medicine for The Brain
We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.
Recent Highlights
News
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
Events
PTSD Awareness Day – June 27, 2018
Home
